Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pancreatic Neoplasms 199Breast Neoplasms 111Carcinoma, Non-Small-Cell Lung 94Triple Negative Breast Neoplasms 66Neoplasm Metastasis 44Neoplasms 42Lung Neoplasms 25Squamous Cell Carcinoma of Head and Neck 24Esophageal Squamous Cell Carcinoma 18Colorectal Neoplasms 18Stomach Neoplasms 17Adenocarcinoma 17Melanoma 15Head and Neck Neoplasms 15Ovarian Neoplasms 12Cholangiocarcinoma 11Carcinoma 11Parkinson Disease 4, Autosomal Dominant Lewy Body 10Gallbladder Neoplasms 10Esophageal Neoplasms 10Carcinoma, Pancreatic Ductal 10Small Cell Lung Carcinoma 9Sarcoma 9Fallopian Tube Neoplasms 9Biliary Tract Neoplasms 9Carcinoma, Squamous Cell 8Neoplasms by Site 7Pancreatic Diseases 6Pancreatic Adenocarcinoma 6Digestive System Neoplasms 6

Interventions

Gemcitabine 3folfirinox 2Oxaliplatin 2Irinotecan 2toripalimab 1surufatinib 1sintilimab 1devimistat 1chloroquine diphosphate 1balstilimab 1Taxes 1Paclitaxel 1Leucovorin 1Injections 1Immune Checkpoint Inhibitors 1Drug Therapy 1Cisplatin 1Chloroquine 1Celecoxib 1130-nm albumin-bound paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Pancreatic Cancer Metastatic × 130-nm albumin-bound paclitaxel × Clear all
NCT05969171 2025-07-30

A Single-center, Prospective, Two Cohort Study of Surufatinib Combined With AG or AG in the First-line Treatment of Locally Advanced or Metastatic Pancreatic Cancer

Fudan University

Phase 2 Recruiting
65 enrolled
Gastrointestinal

Pancreatic Cancer Metastatic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡